Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Skinbiotherap. Share Price
  4. Skinbiotherap. Share Regulatory News
  5. SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Skinbiotherap. Information

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.15
Bid: 10.00
Ask: 10.30
Change: 0.40 (4.10%)
Spread: 0.30 (3.00%)
Open: 9.75
High: 10.15
Low: 9.75
Prev. Close: 9.75
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'

19 Dec 2022 11:15

SkinBioTherapeutics PLC SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities' 19.12.2022 / 12:14 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

19.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:SkinBioTherapeutics PLC
United States
ISIN:GB00BF33H870
EQS News ID:1516547
 
End of NewsEQS News Service

1516547 19.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
4th Dec 20207:00 amRNSFinal Results
2nd Dec 202011:16 amRNSNotice of Results
2nd Nov 20204:15 pmRNSHolding(s) in Company
2nd Nov 20203:49 pmRNSHolding(s) in Company
30th Oct 202012:23 pmRNSResult of General Meeting and Open Offer
14th Oct 20207:00 amRNSPlacing and Open Offer
18th Sep 20204:48 pmRNSGrant of Options
8th Sep 20207:19 amRNSAppointment of Senior Medical Advisor
31st Jul 20207:00 amRNSProduct Development Progress
7th Jul 20207:00 amRNSBusiness Update
26th Jun 20207:00 amRNSChange of Adviser
23rd Jun 20204:29 pmRNSHolding(s) in Company
1st Jun 20203:45 pmRNSHolding(s) in Company
17th Apr 20204:24 pmRNSHolding(s) in Company
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSHalf Year Results
19th Feb 20207:00 amRNSAgreement signed with Winclove Probiotics B.V.
19th Dec 201911:47 amRNSResult of AGM
26th Nov 20198:50 amRNSNotice of AGM
26th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSCommercial Agreement
6th Nov 201910:38 amRNSHolding(s) in Company
28th Aug 20192:05 pmRNSSecond Price Monitoring Extn
28th Aug 20192:00 pmRNSPrice Monitoring Extension
28th Aug 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSBusiness Update and Board Changes
18th Apr 20197:00 amRNSDirector Appointment
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSSkinBiotix shows efficacy in first human study
29th Mar 20197:00 amRNSCEO Designate Appointment
18th Feb 20197:00 amRNSIssue of Equity
14th Feb 20197:00 amRNSHalf year results
1st Feb 20193:30 pmRNSAppointment of Joint Broker
31st Jan 20198:35 amRNSUpdate on human study and IP portfolio extension
31st Jan 20197:00 amRNSUpdate on human studies & IP portfolio extension
20th Nov 20187:00 amRNSCommencement of final phase of human studies
19th Nov 201812:30 pmRNSResult of AGM
7th Nov 20187:00 amRNSSkinBiotix® generates positive data in human study
25th Oct 20187:00 amRNSFull year results
19th Sep 20187:00 amRNSHuman study commenced
18th Sep 20182:05 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
3rd Sep 20187:00 amRNSSkinBiotix technology successful in stability test
16th Aug 201811:05 amRNSSecond Price Monitoring Extn
16th Aug 201811:00 amRNSPrice Monitoring Extension
16th Aug 20187:00 amRNSBusiness Update
3rd Aug 20188:57 amRNSHolding(s) in Company
23rd Jul 20181:13 pmRNSHolding(s) in Company
18th Jul 20187:00 amRNSProvisional ethics approval for human study
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.